Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: Results from phase III trials with dapoxetine

BJU International

Volumn 102, Issue 7, 2008, Pages 824-828

  Shabsigh, Ridwan ^a,b   Patrick, Donald L ^c   Rowland, David L ^d   Bull, Scott A ^e   Tesfaye, Fisseha ^f   Rothman, Margaret ^f  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VALPARAISO UNIVERSITY   (United States)

^e ALZA CORPORATION   (United States)

^f JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Dapoxetine; Perceived control over ejaculation; Premature ejaculation; Sexual dysfunction; Treatment

Indexed keywords

DAPOXETINE; PLACEBO;

ADULT; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE CONTROL; DIZZINESS; DOUBLE BLIND PROCEDURE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 3 CLINICAL TRIAL; PREMATURE EJACULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCALE UP; SEXUAL INTERCOURSE; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

BENZYLAMINES; COITUS; DOUBLE-BLIND METHOD; EJACULATION; HUMANS; MALE; NAPHTHALENES; PATIENT SATISFACTION; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME;

EID: 50949110207     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07845.x     Document Type: Article

References (18)

1. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol 2007 51 : 816 24
2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999 281 : 537 44
3. Patrick DL, Althof SE, Pryor JL et al. Premature ejaculation: an observational study of men and their partners. J Sex Med 2005 2 : 358 67
4. Rowland DL, Patrick DL, Rothman M, Gagnon DD. The psychological burden of premature ejaculation. J Urol 2007 177 : 1065 70
5. Patrick DL, Rowland D, Rothman M. Interrelationships among measures of premature ejaculation: the central role of perceived control. J Sex Med 2007 4 : 780 8
6. McMahon CG, Abdo C, Incrocci L et al. Disorders of orgasm and ejaculation in men. J Sex Med 2004 1 : 58 65
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text revision. Washington, DC : American Psychiatric Association, 2000
8. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998 18 : 274 81
9. Wang WF, Minhas S, Ralph DJ. Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation. Int J Androl 2006 29 : 503 9
10. Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WA, Cleves MA. Tramadol HCl has promise in on-demand use to treat premature ejaculation. J Sex Med 2008 5 : 188 93
11. Safarinejad MR, Hosseini SY. Safety and efficacy of tramadol in the treatment of premature ejaculation: a double- blind, placebo-controlled, fixed- dose, randomized study. J Clin Psychopharmacol 2006 26 : 27 31
12. Atan A, Basar MM, Tuncel A, Ferhat M, Agras K, Tekdogan U. Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation. Urology 2006 67 : 388 91
13. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta- analysis. Int J Impot Res 2004 16 : 369 81
14. Pryor JL, Althof SE, Steidle C et al. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation: integrated analysis of two randomized, double-blind, placebo-controlled trials. Lancet 2006 368 : 929 37
15. Montague DK, Jarow J, Broderick G et al. AUA Guideline on the Pharmacologic Management of Premature Ejaculation. J Urol 2004 172 : 290 4
16. National Center for Health Statistics. International Classification of Diseases, Ninth Revision, Clinical Modifications (ICD-9-CM). Available at: http://www.cdc.gov/nchs/about/otheract/icd9/abticd9.htm
17. United States Food and Drug Administration. FDA Guidance for Industry: Patient-Reported Outcome Measures: Use in Medicinal Product Development to Support Labeling Claims. FDA, February 2006
18. Rosen RC, McMahon CG, Niederberger C, Broderick GA, Jamieson C, Gagnon DD. Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol 2007 177 : 1059 64